+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sufentanil Citrate Injection Market - Global Forecast 2026-2032- Product Image
Sufentanil Citrate Injection Market - Global Forecast 2026-2032- Product Image
Sale

Sufentanil Citrate Injection Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6142731
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sufentanil Citrate Injection Market is projected to reach USD 1.41 Billion in 2026. It is expected to continue growing at a CAGR of 7.97%, reaching USD 2.28 Billion by 2032.

Sufentanil Citrate Injection: Clinical Role and Market Context

Sufentanil citrate injection is a potent synthetic opioid used primarily for analgesia and anesthesia in controlled clinical settings. Its role is closely tied to perioperative care, intensive monitoring, airway management, and institutional protocols designed to balance analgesic benefit with risks such as respiratory depression, sedation, hypotension, and misuse. Demand conditions therefore reflect surgical activity, anesthesiology practice, hospital formularies, regulatory controls, and the availability of trained professionals rather than consumer-facing use.

Healthcare and Regulatory Shifts Reshaping Sufentanil Use

The landscape is being shaped by tighter opioid stewardship, enhanced controlled-substance tracking, and growing emphasis on standardized perioperative pathways. Hospitals are increasingly aligning opioid administration with multimodal analgesia, dose documentation, medication-safety checks, and post-administration observation. At the same time, shortages of injectable medicines, procurement complexity, and uneven access to anesthesiology services can affect continuity of care. These shifts favor suppliers and providers that support reliable quality, traceability, compliant distribution, and evidence-based clinical use.

How Artificial Intelligence Can Improve Safety and Operations

Artificial intelligence can contribute to safer and more efficient use through electronic health-record decision support, risk stratification for respiratory compromise, anomaly detection in controlled-substance transactions, and forecasting of hospital medication needs. Machine-learning tools may also help identify patients who require closer monitoring by integrating comorbidities, concurrent sedatives, age, and procedural factors. However, AI should augment-not replace-anesthesiologist judgment, validated dosing protocols, pharmacovigilance, and human oversight. Governance should address bias, explainability, cybersecurity, data quality, and clinical validation before deployment.

Regional Insights Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America is characterized by mature hospital systems, strong controlled-substance oversight, and broad adoption of electronic medication-management tools. Europe emphasizes harmonized quality standards, opioid stewardship, and national or regional procurement requirements, while Latin America reflects varied regulatory capacity, public-private healthcare structures, and access conditions. The Middle East is supported by investment in tertiary hospitals and surgical infrastructure, alongside differing controlled-medicine rules. Africa faces uneven availability of specialized anesthesia services, essential medicines, and monitoring equipment. Asia-Pacific combines advanced perioperative care in markets such as Japan, South Korea, and Australia with rapidly expanding but heterogeneous healthcare capacity elsewhere. Across all regions, local registration, supply resilience, clinical training, and safe storage remain decisive.

Group-Level Patterns Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN markets present diverse regulatory systems and healthcare capabilities, making local registration, distributor qualification, and clinician education important. BRICS members combine substantial clinical demand with differing procurement models, manufacturing capabilities, and controlled-substance requirements. The European Union benefits from coordinated regulatory principles but retains national differences in reimbursement, hospital purchasing, and prescribing practice. G7 systems generally emphasize advanced pharmacovigilance, opioid stewardship, and digital medication controls. GCC countries are investing in hospital capacity and specialist services while maintaining stringent oversight of controlled medicines. NATO members span varied health systems, but interoperability, emergency preparedness, and secure pharmaceutical supply chains are recurring priorities.

Country Insights: Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, UK, and US

Australia and Canada pair established hospital systems with controlled-medicine governance and attention to supply continuity. Brazil and Mexico operate across diverse public and private settings, where procurement, regional access, and regulatory compliance are central considerations. China and India combine expanding procedural capacity with varied institutional standards and strong interest in reliable domestic and imported pharmaceutical supply. France, Germany, Italy, Spain, and the United Kingdom emphasize regulated hospital use, pharmacovigilance, and structured anesthesia practice, with differences in procurement and reimbursement. Japan and South Korea maintain sophisticated clinical environments with strong medication-safety expectations. The United States has extensive procedural infrastructure and rigorous controlled-substance requirements. Russia’s operating environment is influenced by national regulation, procurement conditions, and supply-chain constraints. In every country, approved indications, product quality, secure handling, and clinician training are fundamental.

Actions for Leaders: Strengthen Safety, Resilience, and Clinical Value

Industry leaders should prioritize validated manufacturing, redundant sourcing of critical inputs, and transparent batch-level traceability. Clinical engagement should focus on evidence-based protocols, multimodal analgesia, respiratory monitoring, and education for anesthesiology, pharmacy, nursing, and emergency teams. Organizations should invest in secure ordering, inventory reconciliation, diversion controls, adverse-event reporting, and readiness for regulatory audits. Digital and AI initiatives should begin with narrowly defined, clinically validated use cases and clear accountability. Market access strategies should be tailored to each jurisdiction’s registration, tendering, reimbursement, and controlled-substance requirements, while partnerships with hospitals and professional bodies can support appropriate use.

Research Methodology for the Sufentanil Citrate Injection Assessment

This executive summary uses a structured qualitative assessment of the product’s clinical role, regulatory context, healthcare delivery environment, technology implications, and geographic coverage. The framework compares regional, country, and economic-group conditions using publicly available categories of evidence such as regulatory standards, hospital-practice guidance, medicine-safety principles, anesthesia infrastructure, procurement patterns, and pharmacovigilance expectations. Findings are synthesized thematically rather than through market estimation. Because conditions differ by jurisdiction and institution, conclusions should be validated against current national labels, formularies, shortage notices, and applicable controlled-substance rules before operational decisions are made.

Conclusion: Responsible Integration into Modern Perioperative Care

Sufentanil citrate injection remains a specialized hospital medicine whose value depends on appropriate patient selection, skilled administration, continuous monitoring, and dependable pharmaceutical quality. The sector is moving toward tighter opioid governance, multimodal pain management, digitally supported medication safety, and more resilient supply chains. Regional and country differences will continue to shape access and operational priorities. Leaders that combine regulatory discipline, clinical education, secure distribution, validated technology, and pharmacovigilance will be best positioned to support safe and appropriate use.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sufentanil Citrate Injection Market, by Product Type
7.1. Introduction
7.2. Ampoule
7.2.1. 5 Mcg Per Ml
7.2.2. 50 Mcg Per Ml
7.3. Prefilled Syringe
7.3.1. 10 Mcg Per Ml
7.3.2. 50 Mcg Per Ml
7.4. Vial
7.4.1. 5 Mcg Per Ml
7.4.2. 50 Mcg Per Ml
8. Sufentanil Citrate Injection Market, by Application
8.1. Introduction
8.2. Emergency
8.2.1. General
8.2.2. Trauma
8.3. Intensive Care
8.3.1. Medical ICU
8.3.2. Surgical ICU
8.4. Operating Room
8.4.1. Cardiac Surgery
8.4.1.1. Adult Cardiac
8.4.1.2. Pediatric Cardiac
8.4.2. General Surgery
8.4.3. Neurosurgery
8.4.4. Orthopedic Surgery
8.5. Outpatient
9. Sufentanil Citrate Injection Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Center
9.3. Clinic
9.3.1. Pain Management Clinic
9.3.2. Specialty Clinic
9.4. Hospital
9.4.1. Private Hospital
9.4.2. Public Hospital
10. Sufentanil Citrate Injection Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Sufentanil Citrate Injection Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Sufentanil Citrate Injection Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Akorn Operating Company LLC
14.2. Akorn, Inc.
14.3. Athenex, Inc.
14.4. AuroMedics Pharma LLC
14.5. Baxter Healthcare Corporation
14.6. Camber Pharmaceuticals, Inc.
14.7. Cipla USA Inc.
14.8. Endo International plc
14.9. Exela Pharma Sciences, LLC
14.10. Fresenius Kabi USA, LLC
14.11. Hikma Pharmaceuticals PLC
14.12. Hikma Pharmaceuticals USA Inc.
14.13. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
14.14. Mallinckrodt plc
14.15. Novartis AG
14.16. Pfizer Inc.
14.17. Piramal Critical Care Inc.
14.18. Sandoz Inc.
14.19. Viatris Inc.
14.20. X-Gen Pharmaceuticals, Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sufentanil Citrate Injection Market, Years Considered for the Study
FIGURE 2. Global Sufentanil Citrate Injection Market, Research Design
FIGURE 3. Global Sufentanil Citrate Injection Market, Research Framework
FIGURE 4. Global Sufentanil Citrate Injection Market, Data Triangulation
FIGURE 5. Global Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sufentanil Citrate Injection Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Sufentanil Citrate Injection Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sufentanil Citrate Injection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Sufentanil Citrate Injection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sufentanil Citrate Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Sufentanil Citrate Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sufentanil Citrate Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Sufentanil Citrate Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sufentanil Citrate Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Sufentanil Citrate Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Sufentanil Citrate Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Sufentanil Citrate Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sufentanil Citrate Injection Market Segmentation & Coverage
TABLE 2. Global Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Ampoule Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ampoule Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ampoule Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 5 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 5 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 5 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 50 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 50 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 50 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global 10 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global 10 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global 10 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global 50 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global 50 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global 50 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global 5 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global 5 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global 5 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global 50 Mcg Per Ml Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global 50 Mcg Per Ml Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global 50 Mcg Per Ml Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 32. Global Emergency Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Emergency Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Emergency Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global General Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global General Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global General Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Trauma Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Trauma Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Trauma Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Intensive Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Intensive Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Intensive Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Medical ICU Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Medical ICU Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Medical ICU Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Surgical ICU Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Surgical ICU Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Surgical ICU Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Operating Room Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Operating Room Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Operating Room Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Cardiac Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Cardiac Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Cardiac Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Adult Cardiac Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Adult Cardiac Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Adult Cardiac Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Pediatric Cardiac Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Pediatric Cardiac Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Pediatric Cardiac Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Neurosurgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Neurosurgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Neurosurgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Outpatient Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Outpatient Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Outpatient Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Global Ambulatory Surgical Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Ambulatory Surgical Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Ambulatory Surgical Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Pain Management Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Pain Management Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Pain Management Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Private Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Private Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Private Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Public Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Public Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Public Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 110. North America Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. North America Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 112. North America Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 113. North America Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 114. North America Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 115. North America Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 116. North America Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 117. North America Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 118. North America Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 119. North America Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 120. North America Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. North America Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 122. North America Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 123. Latin America Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Latin America Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. Latin America Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 126. Latin America Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 127. Latin America Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 128. Latin America Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. Latin America Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 130. Latin America Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 131. Latin America Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 132. Latin America Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 133. Latin America Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Latin America Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 135. Latin America Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 136. Europe Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Europe Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. Europe Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 139. Europe Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 140. Europe Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 141. Europe Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Europe Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 143. Europe Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 144. Europe Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 145. Europe Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 146. Europe Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Europe Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 148. Europe Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 149. Middle East Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Middle East Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Middle East Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 152. Middle East Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 153. Middle East Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 154. Middle East Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Middle East Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 156. Middle East Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 157. Middle East Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 158. Middle East Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 159. Middle East Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 160. Middle East Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 161. Middle East Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 162. Africa Sufentanil Citrate Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Africa Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Africa Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 165. Africa Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 166. Africa Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 167. Africa Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Africa Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 169. Africa Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 170. Africa Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 171. Africa Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 172. Africa Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Africa Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 174. Africa Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 175. Global Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. ASEAN Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. ASEAN Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. ASEAN Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 179. ASEAN Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 180. ASEAN Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 181. ASEAN Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. ASEAN Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 183. ASEAN Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 184. ASEAN Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 185. ASEAN Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 186. ASEAN Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. ASEAN Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 188. ASEAN Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 189. GCC Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. GCC Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. GCC Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 192. GCC Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 193. GCC Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 194. GCC Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. GCC Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 196. GCC Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 197. GCC Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 198. GCC Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 199. GCC Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. GCC Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 201. GCC Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 202. European Union Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. European Union Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 204. European Union Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 205. European Union Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 206. European Union Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 207. European Union Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. European Union Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 209. European Union Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 210. European Union Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 211. European Union Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 212. European Union Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. European Union Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 214. European Union Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 215. BRICS Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 216. BRICS Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. BRICS Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 218. BRICS Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 219. BRICS Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 220. BRICS Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 221. BRICS Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 222. BRICS Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 223. BRICS Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 224. BRICS Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 225. BRICS Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. BRICS Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 227. BRICS Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 228. G7 Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. G7 Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. G7 Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 231. G7 Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 232. G7 Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 233. G7 Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. G7 Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 235. G7 Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 236. G7 Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 237. G7 Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 238. G7 Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. G7 Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 240. G7 Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 241. NATO Sufentanil Citrate Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. NATO Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. NATO Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 244. NATO Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 245. NATO Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 246. NATO Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. NATO Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 248. NATO Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 249. NATO Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 250. NATO Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 251. NATO Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. NATO Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 253. NATO Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 254. Global Sufentanil Citrate Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 255. United States Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 256. United States Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. United States Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 258. United States Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 259. United States Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 260. United States Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. United States Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 262. United States Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 263. United States Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 264. United States Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 265. United States Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. United States Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 267. United States Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 268. Canada Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 269. Canada Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. Canada Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 271. Canada Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 272. Canada Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 273. Canada Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. Canada Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 275. Canada Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 276. Canada Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 277. Canada Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 278. Canada Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Canada Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 280. Canada Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 281. Mexico Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 282. Mexico Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 283. Mexico Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 284. Mexico Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 285. Mexico Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 286. Mexico Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 287. Mexico Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 288. Mexico Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 289. Mexico Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 290. Mexico Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 291. Mexico Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Mexico Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 293. Mexico Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 294. Brazil Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 295. Brazil Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 296. Brazil Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 297. Brazil Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 298. Brazil Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 299. Brazil Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. Brazil Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 301. Brazil Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 302. Brazil Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 303. Brazil Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 304. Brazil Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. Brazil Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 306. Brazil Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 307. United Kingdom Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 308. United Kingdom Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. United Kingdom Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 310. United Kingdom Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 311. United Kingdom Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 312. United Kingdom Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. United Kingdom Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 314. United Kingdom Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 315. United Kingdom Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 316. United Kingdom Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 317. United Kingdom Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 318. United Kingdom Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 319. United Kingdom Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 320. Germany Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 321. Germany Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 322. Germany Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 323. Germany Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 324. Germany Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 325. Germany Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. Germany Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 327. Germany Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 328. Germany Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 329. Germany Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 330. Germany Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. Germany Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 332. Germany Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 333. France Sufentanil Citrate Injection Market Size, 2017-2032 (USD Million)
TABLE 334. France Sufentanil Citrate Injection Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 335. France Sufentanil Citrate Injection Market Size, by Ampoule, 2017-2032 (USD Million)
TABLE 336. France Sufentanil Citrate Injection Market Size, by Prefilled Syringe, 2017-2032 (USD Million)
TABLE 337. France Sufentanil Citrate Injection Market Size, by Vial, 2017-2032 (USD Million)
TABLE 338. France Sufentanil Citrate Injection Market Size, by Application, 2017-2032 (USD Million)
TABLE 339. France Sufentanil Citrate Injection Market Size, by Emergency, 2017-2032 (USD Million)
TABLE 340. France Sufentanil Citrate Injection Market Size, by Intensive Care, 2017-2032 (USD Million)
TABLE 341. France Sufentanil Citrate Injection Market Size, by Operating Room, 2017-2032 (USD Million)
TABLE 342. France Sufentanil Citrate Injection Market Size, by Cardiac Surgery, 2017-2032 (USD Million)
TABLE 343. France Sufentanil Citrate Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 344. France Sufentanil Citrate Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 345. France Sufentanil Citrate Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 346. Russia Sufentanil Citrate Injection Market Siz

Companies Mentioned

  • Akorn Operating Company LLC
  • Akorn, Inc.
  • Athenex, Inc.
  • AuroMedics Pharma LLC
  • Baxter Healthcare Corporation
  • Camber Pharmaceuticals, Inc.
  • Cipla USA Inc.
  • Endo International plc
  • Exela Pharma Sciences, LLC
  • Fresenius Kabi USA, LLC
  • Hikma Pharmaceuticals PLC
  • Hikma Pharmaceuticals USA Inc.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Mallinckrodt plc
  • Novartis AG
  • Pfizer Inc.
  • Piramal Critical Care Inc.
  • Sandoz Inc.
  • Viatris Inc.
  • X-Gen Pharmaceuticals, Inc.

Related Topics

Related Reports

Sufentanil (CAS 56030-54-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Sufentanil (CAS 56030-54-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Isoprenaline Hydrochloride Injection Market - Global Forecast 2026-2032 - Product Image

Isoprenaline Hydrochloride Injection Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Ropivacaine Hydrochloride & Sodium Chloride Injection Market - Global Forecast 2026-2032 - Product Image

Ropivacaine Hydrochloride & Sodium Chloride Injection Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Clindamycin Phosphate Injections Market - Global Strategic Business Report - Product Image

Clindamycin Phosphate Injections Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Water for Injection Market Report 2026 - Product Image

Water for Injection Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.